Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series by Federica Repetto, Lorenza Burzi, Simone Ribero, Pietro Quaglino, Paolo Dapavo

Get full text

Aging Impact in Response to Different Classes of Biological Treatment in Psoriatic Patients: A Real-Life Observational Study by Francois Rosset, Luca Mastorino, Paolo Dapavo, Michela Ortoncelli, Pietro Quaglino, Simone Ribero

Get full text

Seven cancer patients receiving Guselkumab for treatment of moderate-to-severe psoriasis by Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

Get full text

Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study by Federica Repetto, Gabriele Roccuzzo, Lorenza Burzi, Luca Mastorino, Paolo Dapavo, Pietro Quaglino, Simone Ribero

Get full text

Long-term maintenance treatment of psoriasis: the role of calcipotriol/betamethasone dipropionate aerosol foam in clinical practice by Gabriella Fabbrocini, Clara De Simone, Paolo Dapavo, Perigiorgio Malagoli, Alessandro Martella, Piergiacomo Calzavara-Pinton

Get full text

Risk of Reactivation of Latent Tuberculosis in Psoriasis Patients on Biologic Therapies: A Retrospective Cohort from a Tertiary Care Centre in Northern Italy by Luca Mastorino, Paolo Dapavo, Mattia Trunfio, Gianluca Avallone, Marco Rubatto, Andrea Calcagno, Simone Ribero, Pietro Quaglino

Get full text

Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience by Silvia Giordano, Paolo Dapavo, Michela Ortoncelli, Elena Stroppiana, Anna Verrone, Pietro Quaglino, Simone Ribero, Luca Mastorino

Get full text

Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? by Luca Mastorino, Paolo Dapavo, Gianluca Avallone, Martina Merli, Caterina Cariti, Marco Rubatto, Valentina Pala, Pietro Quaglino, Simone Ribero

Get full text

Exploring Psoriasis Inflammatory Microenvironment by NanoString Technologies by Alessia Andrea Ricci, Paolo Dapavo, Luca Mastorino, Gabriele Roccuzzo, Samanta Wolff, Simone Ribero, Paola Cassoni, Rebecca Senetta, Pietro Quaglino

Get full text

PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis by Carlo Giovanni Carrera, Paolo Dapavo, Piergiorgio Malagoli, Luigi Naldi, Luisa Arancio, Francesca Gaiani, Colin Gerard Egan, Marco Di Mercurio, Angelo Cattaneo

Get full text

Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study by Federica Ricceri, Federico Bardazzi, Gionata Buggiani, Martina Burlando, Elena Campione, Monica Corazza, Aldo Cuccia, Paolo Dapavo, Federica Filippi, Leonardo Zichichi, Aurora Parodi, Francesca Prignano

Get full text

Interleukin-17 vs. Interleukin-23 Inhibitors in Pustular and Erythrodermic Psoriasis: A Retrospective, Multicentre Cohort Study by Gianluca Avallone, Carlo Alberto Maronese, Giulia Murgia, Carlo Giovanni Carrera, Luca Mastorino, Gabriele Roccuzzo, Paolo Dapavo, Silvia Alberti-Violetti, Pietro Quaglino, Simone Ribero, Angelo Valerio Marzano

Get full text

Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study by Paolo Dapavo, Niccolò Siliquini, Luca Mastorino, Gianluca Avallone, Martina Merli, Andrea Agostini, Caterina Cariti, Riccardo Viola, Elena Stroppiana, Anna Verrone, Michela Ortoncelli, Pietro Quaglino, Simone Ribero

Get full text

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study by Riccardo G. Borroni, Piergiorgio Malagoli, Luigi Gargiulo, Mario Valenti, Giulia Pavia, Paola Facheris, Emanuela Morenghi, Isotta Giunipero di Corteranzo, Alessandra Narcisi, Michela Ortoncelli, Paolo Dapavo, Antonio Costanzo

Get full text

Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study by Oliviero Rossi, Angelo Piccirillo, Enrico Iemoli, Annalisa Patrizi, Luca Stingeni, Stefano Calvieri, Massimo Gola, Paolo Dapavo, Antonio Cristaudo, Leonardo Zichichi, Laura Losappio, Fabiana Saccheri, Elide Anna Pastorello

Get full text

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study) by Andrea Chiricozzi, Matteo Megna, Alessandro Giunta, Carlo Giovanni Carrera, Paolo Dapavo, Anna Balato, Piergiorgio Malagoli, Stella Mazzoccoli, Aurora Parodi, Silvia Sabatino, Carlotta Buzzoni, Chu-Han Huang, Alessandra Narcisi

Get full text

Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study by Laura Gnesotto, Guido Mioso, Federico Bardazzi, Federica Filippi, Vito Di Lernia, Alberico Motolese, Sergio Di Nuzzo, Andrea Conti, Federica Arginelli, Monica Corazza, Giulia Odorici, Alessandro Borghi, Paolo Gisondi, Luigi Naldi, Paolo Dapavo, Aurora Parodi, Martina Burlando, Stefano Piaserico

Get full text

Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study by Francesco Bellinato, Paolo Gisondi, Angelo Valerio Marzano, Stefano Piaserico, Clara De Simone, Giovanni Damiani, Giuseppe Argenziano, Marina Venturini, Paolo Dapavo, Antonio Costanzo, Matteo Megna, Francesca Prignano, Martina Burlando, Francesca Satolli, Andrea Carugno, Elena Pezzolo, Marco Romanelli, Aldo Cuccia, Giampiero Girolomoni

Get full text

The CANOVA Study Real-World Evidence of Biologic Treatments in Moderate-Severe Psoriasis in Italy: A Gender Perspective by Delia Colombo, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Alessandro Zullo, Fabio Ferri, Martina Fiocchi, Emanuela Zagni

Get full text

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retros... by Andrea Chiricozzi, Anna Balato, Curdin Conrad, Andrea Conti, Paolo Dapavo, Paulo Ferreira, Francesca Maria Gaiani, Luiz Leite, Piergiorgio Malagoli, Pedro Mendes-Bastos, Matteo Megna, Francesco Messina, Alessia Nidegger, Giulia Odorici, Salvatore Panduri, Stefano Piaserico, Leonardo Piscitelli, Francesca Prignano, Simone Ribero, Joana Valerio, Tiago Torres

Get full text